Clinical Trials on Machine Learning in Finland

Total 24 results

University of Turku

Completed

Mobile Cooperation During the Clinical Practicum

Learning

Finland
University of Helsinki
Karolinska Institutet; University of Turku; Folkhälsan Research Center; University... and other collaborators

Recruiting

Language Development Deficits and Early Interactive Music Intervention (BusyBaby)

Language Development Disorders | Language Development | Dyslexia, Developmental

Finland
Kuopio University Hospital
Turku University Hospital

Recruiting

Quantifying the Benefits and Cost-effectiveness of Real-Ear Measurements (REM) for Hearing Aid Fitting (BREM)

Sensorineural Hearing Loss, Bilateral

Finland
University of Oulu
University of Helsinki; Tampere University

Recruiting

Eyes On Lips? Speechreading Skills and Facial Expression Discrimination in Children With and Without Impaired Hearing

Hearing Impairment | Hearing Impaired Children

Finland
Aalto University
Helsinki University Central Hospital; Business Finland

Recruiting

Early Identification of Age-related Hearing Impairment

Hearing Loss, Age-Related

Finland
Rehabilitation Foundation, Finland
Helsinki University Central Hospital; Social Insurance Institution, Finland

Completed

The Effectiveness of Neuropsychological Rehabilitation in Young Dyslexic Adults

Dyslexia

Finland
University of Helsinki
Karolinska Institutet; Helsinki University Central Hospital

Unknown

Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study (SMeDy)

Dyslexia

Finland
Vesa Lahdes

Recruiting

Sound Ear Check (SEC) in Hearing Diagnostics in Young Children

Hearing Loss | Otitis Media With Effusion | Tympanostomy

Finland
Kuopio University Hospital
Turku University Hospital; Oulu University Hospital; University of Helsinki; University... and other collaborators

Active, not recruiting

Children's Bilateral Cochlear Implantation in Finland (FinBiCI)

Hearing Loss | Deafness

Finland
Pfizer

Completed

Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

Meningococcal Vaccine

Finland, Spain, Poland
Helsinki University Central Hospital
University of Helsinki

Recruiting

Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Cholera | Typhoid Fever | Vaccine-Preventable Diseases

Finland
Turku University Hospital
Satakunta Central Hospital

Completed

Tinnitus rTMS 2013

Tinnitus

Finland
University of Massachusetts, Amherst
National Institute on Deafness and Other Communication Disorders (NIDCD)

Active, not recruiting

Hearing Loss and Communication Needs in a Group Care Setting for Older Adults

Age-related Hearing Loss

United States
Lars Rombo

Completed

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Response to Hepatitis A Vaccine

Finland, Sweden
Pfizer

Completed

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Meningococcal Vaccine

Spain, Germany, Finland, Czechia, Poland, Denmark, Sweden
Pfizer

Completed

A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.

Meningococcal Vaccine

United States, Finland, Czechia, Poland
Pfizer

Completed

A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Meningococcal Vaccine

United States, Canada, Finland, Italy, Poland, United Kingdom, Czech Republic, Germany
Augustana College

Recruiting

A Feasibility Study of a Novel, Fully Remote Counseling and Sound Therapy Program for Hyperacusis

Hyperacusis

United States
Pfizer

Completed

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Meningitis | Meningococcal Vaccine | rLP2086 | Repevax | N Meningitidis Serogroup B

Germany, Finland, Poland
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Cytomegalovirus Infection

United Kingdom, United States
IDeA States Pediatric Clinical Trials Network
National Institutes of Health (NIH); University of Nebraska; University of Montana

Active, not recruiting

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool (MoVeUP)

Telemedicine | Pediatric ALL | Vaccine Hesitancy | COVID-19 Vaccines

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom

Clinical Trials on Machine Learning in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations